483 Document: Juno Therapeutics, Inc., Sep 20, 2023

FDANews 483 Juno Therapeutics, Inc. Sep 20 2023 top
Christopher R. Czajka FDA Investigator Michael Araneta FDA Investigator

On Sep 20, 2023, the FDA inspected Juno Therapeutics, Inc.'s Bothell site. Explore the inspectional observations.